Plasma Fractionation market forecast to see 6.3% CAGR to 2028

The Plasma Fractionation market research report provides an in depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. Growth rate, market share captured, and valuation estimates for each region, segment, and company are documented as well.

The plasma fractionation market is projected to reach US$ 40,731.98 million by 2028 from US$ 26,575.83 million in 2021; it is expected to grow at a CAGR of 6.3% during 2021-2028.

Blood plasma is among the emerging method for treating various chronic diseases. The plasma consists of essential components, such as proteins, albumin, globulins, fibrinogen, clotting factors and inhibitors, and others. It is widely used in blood cancer, COVID19, Atrial fibrillation, leukemia, and others. The plasma is separated from the donated blood by using plasma Fractionation. The regulatory agencies are also providing the required approvals for the use of plasma in treatment processes. For instance, in August 2020, the US Food and Drug Administration (USFDA) issued the emergency use authorization (EUA) for convalescent plasma treatment of COVID-19. In addition to this, in February 2021, the USFDA issued an updated guideline for the plasma EUA for COVID19. Thus active involvement and approval by the regulatory and government are expected to encourage the application of blood plasma. The blood plasma can be stored for up to one year by freezing within 24 hours of blood donated to protect the valuable clotting factors and can be used post thawing process. Many blood bank settings are established in every country worldwide, have access to healthcare service providers, and are funded by various governments and other organizations. For instance, in 2021, the American Association of Blood Banks (AABB) granted funding for the research projects such as "Engineering Immunotherapy Resistant Hematopoiesis to Treat High-Risk Acute Myeloid Leukemia" (by Pietro Genovese, BSc, MSc, Ph.D., Assistant Professor in Pediatrics, Gene Therapy Program, Dana-Farber/Boston Children's Cancer and Blood Disorder Center, Dana-Farber Cancer Institute), "New Approaches to Study and Treat Alloantibody-Mediated Diseases Resulting from Blood Transfusions" (by Simon J. Cleary, Ph.D.; Postdoctoral Fellow, Medicine-Pulmonary, University of California.) and others. Thus as per the above-stated factors, the blood plasma fractionation related market in the forecast period.

List of Companies operating in this report are: TransMedics, XVIVO Perfusion, Bridge to Life Ltd, Paragonix Technologies, Inc, OrganOx Limited, Waters Medical Systems LLC, Organ Recovery Systems, Accord Healthcare, Dr. Franz Koehler Chemie GmbH, Preservation Solutions, Inc

Get Sample PDF Copy of Plasma Fractionation Market at:

https://www.theinsightpartners.com/sample/TIPRE00003422/?utm_source=OpenPR&utm_medium=10366

Furthermore, the market is segmented based on type, application, and region in order to study it exhaustively and provide the data in a systematic manner. Speaking of competitive landscape, the study includes a list of leading companies along with their product and service offerings, strategic decisions, SWOT analysis, latest developments, market share captured, growth rate, and valuation. The challenges faced by these companies are analyzed and solutions for them are given as well.

Product: Technology Insights

In terms of product, the global plasma fractionation market is segmented metal, silicone, plastic, glass, and others. The silicone segment held the largest share of the market in 2020, and it is expected to continue its dominance and register the highest CAGR in the market during the forecast period.

Application: Insights

Based on application, the global plasma fractionation market is segmented into neurology, immunology, hematology, critical care, pulmonology, and other applications. The neurology segment is expected to hold the largest share of the market in 2021, and the hematology segment is expected to register the highest CAGR in the market during the forecast period. North America dominates the global plasma fractionation market due to factors such as technological advancement, well-developed healthcare facility centres equipped with modern-age equipment and instruments. North America is dominating the plasma fractionation market in the forecast period. Moreover. Coagulation factors concentrates, clotting factor concentrates, and other plasma-derived products are increasingly being used in the treatment of various hematological disorders, such as hemophilia A and hemophilia B. Hemophilia is a bleeding disorder resulting from a genetic inability of proper clotting of blood. This can cause uncontrollable bleeding, especially after an injury or a surgery. People suffering from hemophilia have lower levels of clotting Factor VIII (8) or Factor IX. The lower the factor levels, greater is the probability of bleeding, which would potentially cause severe health consequences. According to the Centers for Disease Control and Prevention (CDC), the US has ~30,000-33,000 hemophilia patients. The estimated prevalence of hemophilia in the US is 3.7 patients per 100,000 males for hemophilia B and 12 patients per 100,000 males for hemophilia A. The diseases affect people from all ethnic and racial groups. Hemophilia is treated by restoring missing blood-clotting factors, referred to as clotting factor replacement therapy. Thus, the rising prevalence of hematological indications is boosting the plasma fractionation market for the hematology segment.

Have Question? Speak to Analyst at:

https://www.theinsightpartners.com/speak-to-analyst/TIPRE00003422/?utm_source=OpenPR&utm_medium=10366

Several market forces such as drivers and restraints and political, social, economic and technological advancements help shape up the industry in specific manner. All such forces are studied in detail to arrive at a market forecast which can help build the investment strategies in Plasma Fractionation market.

Essential points covered in Plasma Fractionation market report are:-

What will the market size and the growth rate be in 2028?
What are the key growth stimulants of Plasma Fractionation market?
What are the key market trends impacting Plasma Fractionation market valuation?
What are the challenges to market proliferation?
Who are the key vendors in the Plasma Fractionation market?
Which are the leading companies contributing to Plasma Fractionation market valuation?
What was the market share held by each region in 2028?
What is the estimated growth rate and valuation of Plasma Fractionation market in 2028?

Order a Copy of Plasma Fractionation Market Share, Strategies and Forecasts 2021-2028 Research Report at:  https://www.theinsightpartners.com/buy/TIPRE00003422/?utm_source=OpenPR&utm_medium=10366

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876

About Us:           

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.